Abdominal obesity and metabolic syndrome

[1]  F. Schmidt.  Meta-Analysis , 2008 .

[2]  S. Pincock.  Paul Zimmet: fighting the “diabesity” pandemic , 2006, The Lancet.

[3]  Jiang He,et al.  Metabolic syndrome and risk of cardiovascular disease: a meta-analysis. , 2006, The American journal of medicine.

[4]  N. Sattar.  The metabolic syndrome: should current criteria influence clinical practice? , 2006, Current opinion in lipidology.

[5]  R. Eckel,et al.  Preventing cardiovascular disease and diabetes: a call to action from the American Diabetes Association and the American Heart Association. , 2006, Circulation.

[6]  V. Drapeau,et al.  Waist Girth Does Not Predict Metabolic Complications in Severely Obese Men A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances. , 2006, Diabetes Care.

[7]  S. Grundy.  Does a diagnosis of metabolic syndrome have value in clinical practice? , 2006, The American journal of clinical nutrition.

[8]  G. Reaven,et al.  The metabolic syndrome: is this diagnosis necessary? , 2006, The American journal of clinical nutrition.

[9]  Paul M Ridker,et al.  C-reactive protein and other emerging blood biomarkers to optimize risk stratification of vulnerable patients. , 2006, Journal of the American College of Cardiology.

[10]  S. Grundy.  Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy , 2006, Nature Reviews Drug Discovery.

[11]  S. Grundy,et al.  Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. , 2006, Journal of the American College of Cardiology.

[12]  L. Tavazzi,et al.  A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico (GISSI)-Prevenzione scoring. , 2006, American heart journal.

[13]  Richard N Bergman,et al.  Why Visceral Fat is Bad: Mechanisms of the Metabolic Syndrome , 2006, Obesity.

[14]  M. Jensen.  Is Visceral Fat Involved in the Pathogenesis of the Metabolic Syndrome? Human Model , 2006, Obesity.

[15]  J. Després,et al.  Is visceral obesity the cause of the metabolic syndrome? , 2006, Annals of medicine.

[16]  E. Ferrannini.  Is insulin resistance the cause of the metabolic syndrome? , 2006, Annals of medicine.

[17]  Richard W Morris,et al.  Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. , 2005, Archives of internal medicine.

[18]  R. D'Agostino,et al.  Metabolic Syndrome as a Precursor of Cardiovascular Disease and Type 2 Diabetes Mellitus , 2005, Circulation.

[19]  Paul Zimmet,et al.  The metabolic syndrome—a new worldwide definition , 2005, The Lancet.

[20]  Richard Kahn,et al.  The metabolic syndrome: time for a critical appraisal: joint statement from the American Diabetes Association and the European Association for the Study of Diabetes. , 2005, Diabetes care.

[21]  H. Lebovitz,et al.  Point: visceral adiposity is causally related to insulin resistance. , 2005, Diabetes care.

[22]  E. Gale.  The myth of the metabolic syndrome , 2005, Diabetologia.

[23]  G. Reaven.  The metabolic syndrome: requiescat in pace. , 2005, Clinical chemistry.

[24]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[25]  S. Fowler,et al.  The Effect of Metformin and Intensive Lifestyle Intervention on the Metabolic Syndrome: The Diabetes Prevention Program Randomized Trial , 2005, Annals of Internal Medicine.

[26]  J. Després,et al.  Adiponectinemia in visceral obesity: impact on glucose tolerance and plasma lipoprotein and lipid levels in men. , 2005, The Journal of clinical endocrinology and metabolism.

[27]  Muredach P. Reilly,et al.  Mechanisms of the metabolic syndrome , 2004 .

[28]  S. Haffner,et al.  Does the metabolic syndrome improve identification of individuals at risk of type 2 diabetes and/or cardiovascular disease? , 2004, Diabetes care.

[29]  P. Underwood.  Cardiovascular risk, the metabolic syndrome and the hypertriglyceridaemic waist. , 2004, Current opinion in lipidology.

[30]  A. Garg,et al.  Lipodystrophies: rare disorders causing metabolic syndrome. , 2004, Endocrinology and metabolism clinics of North America.

[31]  I. Lemieux.  Energy partitioning in gluteal-femoral fat: does the metabolic fate of triglycerides affect coronary heart disease risk? , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[32]  Claude Lenfant,et al.  Definition of Metabolic Syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association Conference on Scientific Issues Related to Definition , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[33]  A. Gotto,et al.  The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2004, The American journal of cardiology.

[34]  C. Nishida,et al.  Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies , 2004, The Lancet.

[35]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[36]  H. Kahn,et al.  Metabolic risks identified by the combination of enlarged waist and elevated triacylglycerol concentration. , 2003, The American journal of clinical nutrition.

[37]  C. Bouchard,et al.  Targeting the metabolic syndrome with exercise: evidence from the HERITAGE Family Study. , 2003, Medicine and science in sports and exercise.

[38]  T. Jørgensen,et al.  Obesity and central fat pattern among Greenland Inuit and a general population of Denmark (Inter99): Relationship to metabolic risk factors , 2003, International Journal of Obesity.

[39]  P. Tsao,et al.  Insulin resistance and compensatory hyperinsulinemia: the key player between cigarette smoking and cardiovascular disease? , 2003, Journal of the American College of Cardiology.

[40]  L. Niskanen,et al.  Metabolic syndrome and development of diabetes mellitus: application and validation of recently suggested definitions of the metabolic syndrome in a prospective cohort study. , 2002, American journal of epidemiology.

[41]  P. Libby,et al.  Diabetic macrovascular disease: the glucose paradox? , 2002, Circulation.

[42]  Ronald Klein,et al.  Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in Beaver Dam. , 2002, Diabetes care.

[43]  S. Heymsfield,et al.  Waist circumference and obesity-associated risk factors among whites in the third National Health and Nutrition Examination Survey: clinical action thresholds. , 2002, The American journal of clinical nutrition.

[44]  Moyses Szklo,et al.  Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. , 2002, Diabetes.

[45]  Tracey McLaughlin,et al.  Relationship between obesity, insulin resistance, and coronary heart disease risk. , 2002, Journal of the American College of Cardiology.

[46]  J. Hardies,et al.  Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients. , 2002, The Journal of clinical endocrinology and metabolism.

[47]  S. Haffner,et al.  Identification of Persons at High Risk for Type 2 Diabetes Mellitus: Do We Need the Oral Glucose Tolerance Test? , 2002, Annals of Internal Medicine.

[48]  R. Bergman,et al.  Extreme insulin resistance of the central adipose depot in vivo. , 2002, Diabetes.

[49]  P. Havel.  Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin , 2002, Current opinion in lipidology.

[50]  G. Assmann,et al.  Simple Scoring Scheme for Calculating the Risk of Acute Coronary Events Based on the 10-Year Follow-Up of the Prospective Cardiovascular Münster (PROCAM) Study , 2002, Circulation.

[51]  J. Shaw,et al.  Global and societal implications of the diabetes epidemic , 2001, Nature.

[52]  M. Dumont,et al.  Effect of a six month gemfibrozil treatment and dietary recommendations on the metabolic risk profile of visceral obese men , 2001, International Journal of Obesity.

[53]  J. Després,et al.  Elevated C-Reactive Protein: Another Component of the Atherothrombotic Profile of Abdominal Obesity , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[54]  A. Leon,et al.  Response of blood lipids to exercise training alone or combined with dietary intervention. , 2001, Medicine and science in sports and exercise.

[55]  T. Rice,et al.  FAMILIAL AGGREGATION OF CARDIOVASCULAR RESPONSE TO SUBMAXIMAL EXERCISE IN THE HERITAGE FAMILY STUDY , 2001 .

[56]  J. Després,et al.  Treatment of obesity: need to focus on high risk abdominally obese patients , 2001, BMJ : British Medical Journal.

[57]  GS Hotamisligil,et al.  Molecular mechanisms of insulin resistance and the role of the adipocyte , 2000, International Journal of Obesity.

[58]  A. Astrup,et al.  Redefining Type 2 diabetes: ‘Diabesity’ or ‘Obesity Dependent Diabetes Mellitus’? , 2000, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[59]  R. Hegele.  Insulin resistance in human partial lipodystrophy , 2000, Current atherosclerosis reports.

[60]  E. Danforth.  Failure of adipocyte differentiation causes type II diabetes mellitus? , 2000, Nature Genetics.

[61]  C. Bouchard,et al.  Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[62]  Robert Ross,et al.  Reduction in Obesity and Related Comorbid Conditions after Diet-Induced Weight Loss or Exercise-Induced Weight Loss in Men , 2000, Annals of Internal Medicine.

[63]  D. Gaudet,et al.  Hypertriglyceridemic waist: A marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men? , 2000, Circulation.

[64]  G. Shulman,et al.  Mechanism of Insulin Resistance in A-ZIP/F-1 Fatless Mice* , 2000, The Journal of Biological Chemistry.

[65]  G. Shulman,et al.  Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice. , 2000, The Journal of clinical investigation.

[66]  M. Laakso,et al.  Hyperglycemia and cardiovascular disease in type 2 diabetes. , 1999, Diabetes.

[67]  S. Coppack,et al.  C-reactive protein in healthy subjects: associations with obesity, insulin resistance, and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[68]  R. Holman,et al.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.

[69]  P. Zimmet,et al.  Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[70]  D. Levy,et al.  Prediction of coronary heart disease using risk factor categories. , 1998, Circulation.

[71]  J. Conway,et al.  Intraabdominal adipose tissue and anthropometric surrogates in African American women with upper- and lower-body obesity. , 1997, The American journal of clinical nutrition.

[72]  J. Albu,et al.  Visceral Fat and Race-Dependent Health Risks in Obese Nondiabetic Premenopausal Women , 1997, Diabetes.

[73]  J. Lovejoy,et al.  Abdominal fat distribution and metabolic risk factors: effects of race. , 1996, Metabolism: clinical and experimental.

[74]  T. Funahashi,et al.  cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). , 1996, Biochemical and biophysical research communications.

[75]  E. Shafrir,et al.  Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. , 1996, Diabetes & metabolism.

[76]  Philipp E. Scherer,et al.  A Novel Serum Protein Similar to C1q, Produced Exclusively in Adipocytes (*) , 1995, The Journal of Biological Chemistry.

[77]  C. Morrison,et al.  Waist circumference as a measure for indicating need for weight management , 1995, BMJ.

[78]  J. Després,et al.  Regional variation in adipose tissue metabolism of severely obese premenopausal women. , 1995, Journal of lipid research.

[79]  A. Kissebah,et al.  Regional adiposity and morbidity. , 1994, Physiological reviews.

[80]  A Tremblay,et al.  Visceral Obesity in Men: Associations With Glucose Tolerance, Plasma Insulin, and Lipoprotein Levels , 1992, Diabetes.

[81]  P. Björntorp.  Metabolic Implications of Body Fat Distribution , 1991, Diabetes Care.

[82]  A Tremblay,et al.  Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease. , 1990, Arteriosclerosis.

[83]  A Tremblay,et al.  The response to long-term overfeeding in identical twins. , 1990, The New England journal of medicine.

[84]  E. Barrett-Connor,et al.  Cigarette smoking and increased central adiposity. , 1989, Annals of internal medicine.

[85]  R. Andres,et al.  Studies in the distribution of body fat. III. Effects of cigarette smoking. , 1989, JAMA.

[86]  J. File.  Requiescat in pace. , 1987, Canadian family physician Medecin de famille canadien.

[87]  J. Després,et al.  We-S14:3 From CVD risk to cardiometabolic risk , 2006 .

[88]  Y. Matsuzawa.  Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease , 2006, Nature Clinical Practice Cardiovascular Medicine.

[89]  Neil R. Powe,et al.  The Atherosclerosis Risk in Communities Study , 2006 .

[90]  D. Moller,et al.  Metabolic syndrome: a clinical and molecular perspective. , 2005, Annual review of medicine.

[91]  R. Califf,et al.  Metabolic syndrome: definition, pathophysiology, and mechanisms. , 2005, American heart journal.

[92]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[93]  A. Mokdad,et al.  Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001. , 2003, JAMA.

[94]  J. Mckenney,et al.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.

[95]  M. Moore.  Fasting insulin and apolipoprotein B levels and low density lipoprotein particle size as risk factors for ischemic heart disease. , 1998, Journal of insurance medicine.